Pyxis Oncology (PYXS) Balance Sheet: Assets & Liabilities

Pyxis Oncology (PYXS) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Pyxis Oncology reported total assets of $91.52M and total liabilities of $38.11M. Shareholders' equity was $53.41M, down 55.8% from $120.75M a year earlier. Total debt stood at $18.67M against $66.86M in cash and short-term investments, a net cash position of $48.18M. That puts debt-to-equity at 0.35, compared with 0.18 a year earlier.

Pyxis Oncology Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Pyxis Oncology, Inc. (PYXS) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	15.42	19.47	9.66	179.29	274.74	8.08	19.69
Short-Term Investments	51.44	107.46	109.63	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	66.86	126.93	119.30	179.29	274.74	8.08	19.69
Accounts Receivable	0.70	0.00	0.02	0.60	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.49	3.28	2.82	3.94	3.94	0.02	0.01
Total Current Assets	72.11	132.44	124.60	186.61	278.67	8.10	19.70
Non-Current Assets
Property, Plant & Equipment (Net)	19.42	22.14	24.81	24.77	1.24	1.94	0.08
Intangible Assets	0.00	2.60	24.31	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.11	0.11	0.03
Total Non-Current Assets	19.42	24.74	49.12	24.77	1.35	2.05	0.11
Total Assets	91.52	157.18	173.73	211.38	280.02	10.15	19.81
Current Liabilities
Accounts Payable	10.89	4.86	3.90	7.10	11.95	1.08	0.49
Short-Term Debt	1.69	2.90	1.23	0.00	0.17	0.62	0.01
Accrued Liabilities	4.81	6.75	7.40	19.21	6.59	1.88	-
Deferred Revenue	0.00	0.00	7.66	0.00	0.00	0.00	0.00
Other Current Liabilities	0.43	0.64	0.36	1.09	0.27	1.93	0.12
Total Current Liabilities	21.13	17.68	25.76	31.63	18.71	3.69	0.73
Non-Current Liabilities
Long-Term Debt	16.98	18.75	20.10	18.92	0.00	0.17	0.01
Deferred Tax Liabilities	0.00	0.00	2.16	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	2.16	0.00	0.00	21.94	21.94
Total Non-Current Liabilities	16.98	18.75	22.26	18.92	0.00	22.11	21.95
Total Liabilities	38.11	36.43	48.02	50.56	18.71	25.80	22.68
Stockholders' Equity
Common Stock	0.06	0.06	0.05	0.03	0.03	0.00	0.00
Retained Earnings	-443.18	-363.56	-286.23	-212.44	-91.72	-15.74	-2.92
Accumulated Other Comprehensive Income	0.05	0.17	0.06	0.00	0.00	0.00	0.00
Additional Paid-in Capital	496.47	484.08	411.82	373.23	353.00	0.10	0.04
Shares Outstanding	62.69	59.97	44.75	34.96	32.22	-	-
Total Stockholders' Equity	53.41	120.75	125.70	160.82	261.31	-15.65	-2.87
Total Liabilities & Equity	91.52	157.18	173.73	211.38	280.02	10.15	19.81

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Pyxis Oncology Balance Sheet

How much debt does Pyxis Oncology have?

Pyxis Oncology had total debt of $18.67M as of Dec 31, 2025, against $66.86M in cash and short-term investments. Its debt-to-equity ratio was 0.35. Total debt was $21.65M a year earlier.

What are Pyxis Oncology's total assets?

Pyxis Oncology reported total assets of $91.52M as of Dec 31, 2025, down 41.8% from $157.18M a year earlier. Total liabilities were $38.11M.

What is Pyxis Oncology's shareholders' equity?

Pyxis Oncology's shareholders' equity was $53.41M as of Dec 31, 2025, or about $0.85 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition